Alcami Corporation

33 articles with Alcami Corporation

• Alcami Providing Commercial Manufacturing for Trevena's Recently FDA Approved OLINVYK™

  8/26/2020

   Alcami, a US-based contract development and manufacturing organization (CDMO), announced today that it is providing commercial manufacturing services for Trevena's newly approved OLINVYK. OLINVYK (oliceridine) injection is an opioid approved in adults for the management of acute pain severe enough to require an intravenous opioid

• 

  BioSpace Movers & Shakers, June 5

  6/5/2020

  Biopharma and life sciences companies bolster their leadership teams and board with these Movers & Shakers.

• Alcami Appoints Walter J. Kaczmarek III as Chief Executive Officer

  6/4/2020

   Alcami, a United States -based contract development and manufacturing organization (CDMO), announced today the appointment of Walter J. Kaczmarek III as Chief Executive Officer. Mr. Kaczmarek, who has over 30 years of experience in the pharmaceutical industry, will focus on advancing Alcami's next phase of strategic growth. 

• Alcami Continues to Strengthen Senior Leadership Team with Appointment of Quality and Regulatory Leaders

  5/21/2020

  Alcami, a North Carolina-based contract development and manufacturing organization, announced further additions to strengthen its senior leadership team.

• Alcami Appoints EVP of Drug Product Operations and VP of Laboratory Operations

  5/18/2020

  Alcami, a North Carolina-based contract development and manufacturing organization, announced the appointment of Ken Domagalski and Elliott Franco to their Senior Leadership Team.

• Alcami Expands its Sterile Fill-Finish Capacity with Acquisition of TriPharm Services

  1/17/2020

  Transaction Advances Alcami's Strategic Plan by Adding Scale in Attractive and Growing Parenteral Markets

• Alcami Announces Sale of its Weert, Netherlands Facility

  1/8/2020

  Next Step in Alcami's Strategic Plan to Focus its Platform on High-Growth Market Segments

• 

  Bio NC Hotbed Region: Over 100% Growth This Century

  3/26/2019

  Anchored by Raleigh, Durham and the Research Triangle Park region, BioSpace’s Bio NC Hotbed is one of the faster-growing areas for biopharma in the U.S.

• Alcami Kickstarts Biologics Enterprise to Advance Treatments for Complex Medical Conditions

  3/19/2019

  Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, launched Alcami Biologics, the organization's new biopharmaceutical development, analytical testing, manufacturing, and packaging enterprise.

• Alcami Helps Medicines Development for Global Health Secure FDA Approval of Moxidectin for River Blindness

  10/25/2018

  Alcami Corporation announced today its collaboration with Medicines Development for Global Health (MDGH), a not-for-profit Australian biopharmaceutical company dedicated to the development of affordable medicines and vaccines for neglected diseases prevalent in low and middle-income countries.

• Alcami Renews Partnership with Wisconsin Department of Natural Resources to Revitalize State Trails

  7/18/2018

  Alcami Corporation announced a renewed partnership with the Wisconsin Department of Natural Resources (DNR) to revitalize and repair the Hank Aaron State Trail in Milwaukee, Wisconsin, and the Pike Lake Hiking Trail in Hartford, Wisconsin.

• Alcami Announces Donation to Wilmington, North Carolina Fire Department

  6/14/2018

  Alcami Corporation announced today its $15,000 donation to the Wilmington, North Carolina Fire Department (WFD) to help fund IvyGene® cancer screenings for firefighters.

• Alcami's Extended Workbench Supports Commercial Supply of Flexion Therapeutics's ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)

  6/13/2018

  Alcami Corporation announced the expanded deployment of its Extended Workbench laboratory services program to support the ongoing manufacturing and development of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension).

• Alcami to Become Industry Leading Platform CDMO Following Acquisition by Madison Dearborn Partners - duplicate

  6/1/2018

  Alcami Corporation announced it has reached an agreement to be acquired by Madison Dearborn Partners, LLC (MDP).

• Alcami to Become Industry Leading Platform CDMO Following Acquisition by Madison Dearborn Partners

  6/1/2018

  MDP will acquire a majority ownership position in Alcami from existing shareholder Ares Capital Corporation

• Alcami Announces Industry-Leading Analytical Testing Turnaround Time

  5/8/2018

  Alcami continues to set the industry standard with its analytical testing offering, and through operational excellence, streamlined processes, and technical knowledge and expertise, has reduced timelines by up to 30 percent.

• Alcami St. Louis Facility to be Honored by Missouri House of Representatives and City of St. Louis

  5/3/2018

  Alcami Corporation announces the Missouri House of Representatives and St. Louis Mayor Lyda Krewson will honor Alcami with a resolution and letter of commendation.

• Fueled by Growth, Alcami Unveils New Sales Office in Cambridge, MA

  2/14/2018

  The Kendall Square facility will support robust customer growth and connect Alcami to the forefront of hundreds of thriving pharma and biotech start-ups and innovators.

• Alcami Furthers Expansion with New West Coast Sales Office

  11/15/2017

  The facility will support the company's thriving West Coast customer base and will help accelerate growth through new regional partnerships.

• Alcami Announces Manufacturing Agreement for Solasia's Active Pharmaceutical Ingredient Darinaparsin

  11/9/2017

  The company has finalized manufacturing and quality agreements with Solasia Pharma, K.K.